Results 241 to 250 of about 42,414 (275)

Cytology of the Urine in Children after Oral Poliovirus Vaccine

New England Journal of Medicine, 1965
ALTHOUGH many viruses have been isolated from the urine1 2 3 4 5 6 7 8 9 10 11 during systemic viral illnesses there have been relatively few correlative cytologic investigations of the urinary sediment.6 , 12 , 13 The relation of urinary cells with intranuclear inclusion bodies and cytomegalic inclusion disease is well established.6 , 12 , 14 Recently,
Audrey F. Hart, James D. Cherry, Marie Wartolec   +2 more
openaire   +3 more sources

Mucosal immunity following oral poliovirus vaccine and enhanced potency inactivated poliovirus vaccine immunization

Pediatric Infectious Disease, 1991
Mucosal immunity is considered to be an important barrier for inhibiting person-to-person transmission of naturally occurring (wild type) poliovirus infection. This review briefly summarizes the results of a previously published study in which 79 oral poliovirus vaccine (OPV) vaccinated children and 93 enhanced-potency inactivated poliovirus vaccine ...
openaire   +2 more sources

Live Oral Poliovirus Vaccine, Type III

JAMA: The Journal of the American Medical Association, 1970
To the Editor.— Early fears that live oral poliovirus vaccine, monovalent type III might produce disease in the young adult group have not been borne out in the military population. The US Army has administered type III live oral poliovirus vaccine to more than 3.5 million young adults since 1963.
openaire   +2 more sources

Oral Poliovirus Vaccines

JAMA, 1964
Adam, Sheretz Rc
openaire   +3 more sources

Optimal schedule for the administration of oral poliovirus vaccine

1993
The optimal schedule for the administration of oral poliovirus vaccine (OPV) can be based on a simple paradigm in which the period of maximum risk from natural infection is balanced by the influence of factors which may affect the immune response to vaccination.
Peter A. Patriarca, Walter A. Orenstein, Robert W. Linkins, Roland W. Sutter   +3 more
openaire   +2 more sources

Change from oral poliovirus vaccine to inactivated poliovirus vaccine

The Lancet, 2002
Stefania Salmaso, Tom Jefferson, Elisabetta Franco, Alfonso Mele   +3 more
openaire   +2 more sources

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label, randomised, controlled trial.

Lancet. Infectious Diseases (Print), 2020
Hanqing He, Yamin Wang, X. Deng, C. Yue, Xuewen Tang, Yan Li, Yan Liu, Z. Yin, Guoping Zhang, Zhongbing Chen, S. Xie, N. Wen, Z. An, Zhi-ping Chen, Huaqing Wang   +14 more
semanticscholar   +1 more source

VIREMIA IN INFANTS VACCINATED WITH ORAL POLIOVIRUS VACCINE (SABIN)1*

American Journal of Epidemiology, 1964
Belem Llado, Dorothy M. Horstmann, Ruth Klemperer, Alfred J. Vignec, Edward M. Opton   +4 more
openaire   +3 more sources

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao, Xuesong Han, Leticia M Nogueira   +2 more
exaly